Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study

Ricardo Costeira, Karla A. Lee, Benjamin Murray, Colette Christiansen, Juan Castillo-Fernandez, Mary Ni Lochlainn, Joan Capdevila Pujol, Heather Macfarlane, Louise C. Kenny, Iain Buchan, Jonathon Wolf, Janice Rymer, Sebastien Ourselin, Claire J. Steves, Timothy D. Spector, Louise R. Newson, Jordana T. Bell
doi: https://doi.org/10.1101/2020.07.30.20164921
Ricardo Costeira
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karla A. Lee
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Murray
2School of Biomedical Engineering & Imaging Sciences, King’s College London, London, U.K
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colette Christiansen
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Castillo-Fernandez
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Ni Lochlainn
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan Capdevila Pujol
3Zoe Global Limited, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Macfarlane
4National Health Service, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise C. Kenny
5Department of Women’s and Children’s Health, University of Liverpool, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain Buchan
6Department of Public Health, Policy and Systems, University of Liverpool, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathon Wolf
3Zoe Global Limited, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice Rymer
7Department of Women’s Health, King’s College London, London, U.K
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Ourselin
2School of Biomedical Engineering & Imaging Sciences, King’s College London, London, U.K
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire J. Steves
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy D. Spector
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise R. Newson
8Newson Health Menopause & Wellbeing Centre, Stratford-Upon-Avon, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordana T. Bell
1Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jordana.bell@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Men and older women have been shown to be at higher risk of adverse COVID-19 outcomes. Animal model studies of SARS-CoV and MERS suggest that the age and sex difference in COVID-19 symptom severity may be due to a protective effect of the female sex hormone estrogen. Females have shown an ability to mount a stronger immune response to a variety of viral infections because of more robust humoral and cellular immune responses.

Objectives We sought to determine whether COVID-19 positivity increases in women entering menopause. We also aimed to identify whether premenopausal women taking exogenous hormones in the form of the combined oral contraceptive pill (COCP) and post-menopausal women taking hormone replacement therapy (HRT) have lower predicted rates of COVID-19, using our published symptom-based model.

Design The COVID Symptom Study developed by King’s College London and Zoe Global Limited was launched in the UK on 24th March 2020. It captured self-reported information related to COVID-19 symptoms. Data used for this study included records collected between 7th May - 15th June 2020.

Main outcome measures We investigated links between COVID-19 rates and 1) menopausal status, 2) COCP use and 3) HRT use, using symptom-based predicted COVID-19, tested COVID-19, and disease severity based on requirement for hospital attendance or respiratory support.

Participants Female users of the COVID Symptom Tracker Application in the UK, including 152,637 women for menopause status, 295,689 for COCP use, and 151,193 for HRT use. Analyses were adjusted for age, smoking and BMI.

Results Post-menopausal women aged 40-60 years had a higher rate of predicted COVID (P=0.003) and a corresponding range of symptoms, with consistent, but not significant trends observed for tested COVID-19 and disease severity. Women aged 18-45 years taking COCP had a significantly lower predicted COVID-19 (P=8.03E-05), with a reduction in hospital attendance (P=0.023). Post-menopausal women using HRT or hormonal therapies did not exhibit consistent associations, including increased rates of predicted COVID-19 (P=2.22E-05) for HRT users alone.

Conclusions Our findings support a protective effect of estrogen on COVID-19, based on positive association between predicted COVID-19 and menopausal status, and a negative association with COCP use. HRT use was positively associated with COVID-19 symptoms; however, the results should be considered with caution due to lack of data on HRT type, route of administration, duration of treatment, and potential comorbidities.

Trial registration The App Ethics has been approved by KCL ethics Committee REMAS ID 18210, review reference LRS-19/20-18210

Competing Interest Statement

Zoe Global Limited co-developed the app pro bono for non-commercial purposes. Investigators received support from the Wellcome Trust, the MRC/BHF, EU, NIHR, CDRF, and the NIHR-funded BioResource, Clinical Research Facility and BRC based at GSTT NHS Foundation Trust in partnership with KCL. Zoe authors work for Zoe Global Limited and TDS is a consultant to Zoe Global Limited. IB is NIHR Senior Investigator and Chief Data Scientist Advisor for AstraZeneca.

Clinical Trial

The App Ethics has been approved by KCL ethics Committee REMAS ID 18210, review reference LRS-19/20-18210 and all subscribers provided consent. ClinicalTrials.gov Identifier of app: NCT04331509

Funding Statement

Zoe Global Limited provided in kind support for all aspects of building, running, and supporting the app and service to all users worldwide. Investigators received support from the Wellcome Trust, the MRC/BHF, Alzheimers Society, EU, NIHR, CDRF. The TwinsUK study was funded by the Wellcome Trust; European Communitys Seventh Framework Programme (FP7/20072013); National Institute for Health Research (NIHR) funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guys and St Thomas NHS Foundation Trust in partnership with Kings College London.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The App Ethics has been approved by KCL ethics Committee REMAS ID 18210, review reference LRS-19/20-18210 and all subscribers provided consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used in this study is available to bona fide researchers through UK Health Data Research using the following link https://healthdatagateway.org/detail/9b604483-9cdc-41b2-b82c-14ee3dd705f6

https://healthdatagateway.org/detail/9b604483-9cdc-41b2-b82c-14ee3dd705f6

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 02, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study
Ricardo Costeira, Karla A. Lee, Benjamin Murray, Colette Christiansen, Juan Castillo-Fernandez, Mary Ni Lochlainn, Joan Capdevila Pujol, Heather Macfarlane, Louise C. Kenny, Iain Buchan, Jonathon Wolf, Janice Rymer, Sebastien Ourselin, Claire J. Steves, Timothy D. Spector, Louise R. Newson, Jordana T. Bell
medRxiv 2020.07.30.20164921; doi: https://doi.org/10.1101/2020.07.30.20164921
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study
Ricardo Costeira, Karla A. Lee, Benjamin Murray, Colette Christiansen, Juan Castillo-Fernandez, Mary Ni Lochlainn, Joan Capdevila Pujol, Heather Macfarlane, Louise C. Kenny, Iain Buchan, Jonathon Wolf, Janice Rymer, Sebastien Ourselin, Claire J. Steves, Timothy D. Spector, Louise R. Newson, Jordana T. Bell
medRxiv 2020.07.30.20164921; doi: https://doi.org/10.1101/2020.07.30.20164921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (417)
  • Anesthesia (93)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (398)
  • Epidemiology (8597)
  • Forensic Medicine (4)
  • Gastroenterology (391)
  • Genetic and Genomic Medicine (1775)
  • Geriatric Medicine (170)
  • Health Economics (376)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (198)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10355)
  • Intensive Care and Critical Care Medicine (554)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (934)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (256)
  • Pediatrics (541)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1788)
  • Public and Global Health (3877)
  • Radiology and Imaging (629)
  • Rehabilitation Medicine and Physical Therapy (324)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (171)
  • Sports Medicine (159)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)